Edward Carr

Chief Accounting Officer, Dianthus Therapeutics, Inc. /DE/

Bought, 12 months

$0.0M

Sold, 12 months

$5.6M

Companies

Latest trade

Sep 17, 2026

Companies

Dianthus Therapeutics, Inc. /DE/Chief Accounting Officer −$5.6M

Trades

DNTH Sold 20,000 shares at $101.38 · planned $2.0M Sep 17

DNTH Sold 43,682 shares at $81.49 · planned $3.6M Mar 12

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.